Hope Not Lost in Dismissed Dabigatran Class Action

While a federal judge has decided to dismiss a class action lawsuit against the makers of Pradaxa (dabigatran), the judge is also letting the plaintiff pursue an individual lawsuit against the defendants in a failure-to-warn claim.

As with many claims filed against manufacturer Boehringer Ingelheim, this lawsuit, filed by plaintiff Mark A. Jackson, accuses the drug company of not properly warning the public or healthcare professionals of the dangers linked to dabigatran use. Dabigatran is an anticoagulant medication that is used to treat atrial fibrillation (AF), which is a heart condition that causes irregular heartbeat and flutters. Dabigatran has been linked to excessive and irreversible bleeding since its release. That risk has caused numerous plaintiffs to file claims against the manufacturers.

Jackson’s class action lawsuit claim may have been dismissed in an Order (PDF) that was handed down on July 18, but Chief District Judge David R. Herndon also denied the manufacturer’s motion to dismiss all of the counts held against it. The judge did dismiss the class action suit but he also allowed the plaintiffs to file individual lawsuits in its place. In dismissing the class action claim, Judge Herndon said the plaintiff could amend the lawsuit and request class action status again later.

Herndon also made note that “given the nature of the case, it is highly unlikely that the requirements for a statewide class under the law of Louisiana would be met and that a nationwide class is likely unmanageable.”

Other drugs are used to treat AF as well. Common drugs used to treat AF flutters include anticoagulants like Multaq. Multaq is made by Sanofi-Aventis and has been linked to serious side effects including a worsening of the heart condition, liver failure and lung toxicity. It is for this reason that the FDA has recommended that doctors only prescribe Multaq if all other medications fail to work.

If you or a loved one has suffered from liver failure or a worsening heart condition after being treated with Multaq, contact the attorneys at Greg Jones today for a free consultation. I am experienced at fighting Multaq lawsuits and may be able to help you recover money for your injuries.

Share this article

You May Also Like

All Rights Reserved 2016